skip to content National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Skip to subnavigation.
Programs & Resources
skip sub-navigation, go to content.
Linking Haplotypes and Genetic Variation with Cancer Risk Assessment, Prevention, Detection and Treatment Workshop

Workshop Dates

December 4 - 5, 2003

Conference Site

Bethesda Marriott Hotel
5151 Pooks Hill Road
Bethesda, MD 20814

Goals

  • To review the status of the human haplotype map and haplotype analysis with relevance to cancer
  • To assess the current status and needs of SNPs and haplotype research in human populations
  • To recommend the future directions of application of haplotypes and genetic variation for studying cancer prevention, risk assessment, early detection, and treatment

Cosponsored by

  • National Cancer Institute (NCI)
    • Division of Cancer Prevention (DCP)
    • Division of Cancer Treatment and Diagnosis (DCTD)
    • Division of Cancer Control and Population Sciences (DCCPS)
  • National Human Genome Research Institute (NHGRI)

Meeting Materials

Point of Contact

For additional information or questions about this event, please contact the DCP Webmaster.